Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice.
about
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative DisordersCounteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer's disease.A New Venue of TNF Targeting.Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation.Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines
P2860
Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Peripheral administration of t ...... rm potentiation in 5xFAD mice.
@en
Peripheral administration of t ...... rm potentiation in 5xFAD mice.
@nl
type
label
Peripheral administration of t ...... rm potentiation in 5xFAD mice.
@en
Peripheral administration of t ...... rm potentiation in 5xFAD mice.
@nl
prefLabel
Peripheral administration of t ...... rm potentiation in 5xFAD mice.
@en
Peripheral administration of t ...... rm potentiation in 5xFAD mice.
@nl
P2093
P2860
P1476
Peripheral administration of t ...... rm potentiation in 5xFAD mice.
@en
P2093
Christopher M Norris
George T Kannarkat
Kathryn P MacPherson
Lindsey Sniffen
Mary E Wildner
Pradoldej Sompol
P2860
P356
10.1016/J.NBD.2017.02.010
P577
2017-02-24T00:00:00Z